BDR Pharma signs voluntary licensing agreement with Lilly for baricitinib
Lilly had recently announced seven other voluntary license agreements with major drug manufacturers in India for the production of…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
restricted emergency use
Lilly signs licensing agreements with Cipla, Lupin and Sun Pharma for Baricitinib in India
Lilly has recently received permission for restricted emergency use by CDSCO for baricitinib to be used in combination with…
Cipla signs licensing deal with Lilly to manufacture and commercialise baricitinib in India
Baricitinib was issued a restricted emergency use approval by CDSCO to treat COVID-19
Recipients cannot choose between two COVID vaccine options for now: GoI
1.1 crore doses of Covishield from the Serum Institute of India and 55 lakh doses of Covaxin from Bharat Biotech - will be…
DCGI approves Itolizumab for restricted emergency use in COVID-19 treatment
The approval was given after its clinical trials on COVID-19 patients in India was found satisfactory by an expert committee,…
Cipla, Hetero get DCGI nod to manufacture remdesivir
With this move, domestic production of remdesivir for “restricted emergency use” can begin